NYSE:MANE

Veradermics (MANE) Stock Price, News & Analysis

$103.88 +1.09 (+1.06%)
Closing price 03:58 PM Eastern
Extended Trading
$104.50 +0.62 (+0.60%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Veradermics Stock (NYSE:MANE)

Advanced

Key Stats

Today's Range
$100.49
$107.32
50-Day Range
$67.66
$114.58
52-Week Range
$32.00
$117.71
Volume
615,951 shs
Average Volume
504,331 shs
Market Capitalization
$4.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$114.20
Consensus Rating
Moderate Buy

Company Overview

Receive MANE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Veradermics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MANE Stock News Headlines

Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillion in stored capital will be looking for a home when it does. But the real opportunity isn't the IPO itself. Jovine has identified a small-cap supplier trading near $4 that sits directly in the path of xAI's Colossus infrastructure buildout - and a specific trigger in the S-1 could reprice it overnight.tc pixel
See More Headlines

MANE Stock Analysis - Frequently Asked Questions

Veradermics' stock was trading at $43.46 on February 16, 2026. Since then, MANE stock has increased by 139.0% and is now trading at $103.88.

Veradermics, Incorporated (NYSE:MANE) announced its quarterly earnings results on Tuesday, May, 12th. The company reported ($1.32) earnings per share for the quarter, missing analysts' consensus estimates of ($0.56) by $0.76.

Veradermics (MANE) raised $226 million in an initial public offering (IPO) on Wednesday, February 4th 2026. The company issued 15,077,647 shares at $14.00-$16.00 per share.

Veradermics's lock-up period expires on Monday, August 3rd. Veradermics had issued 15,077,647 shares in its IPO on February 4th. The total size of the offering was $256,319,999 based on an initial share price of $17.00. After the end of the company's lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Shares of MANE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/12/2026
Today
6/23/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:MANE
CIK
1827635
Web
N/A
Fax
N/A
Employees
19
Year Founded
N/A

Price Target and Rating

High Price Target
$136.00
Low Price Target
$75.00
Potential Upside/Downside
+9.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.63
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
41,779,000
Free Float
N/A
Market Cap
$4.34 billion
Optionable
N/A
Beta
N/A
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:MANE) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners